Matches in Nanopublications for { ?s ?p "[This indicates that persistent expression of the MET oncogene is mandatory until the advanced phases of cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP747879.RAsU9gdUwmQibS7R7R1r-Ut-WksgRy2iw2oZ4xaUG_8BM130_assertion description "[This indicates that persistent expression of the MET oncogene is mandatory until the advanced phases of cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747879.RAsU9gdUwmQibS7R7R1r-Ut-WksgRy2iw2oZ4xaUG_8BM130_provenance.
- NP615947.RAbs2vNyOV-0IXmBNNRUe3_WJoVKO1qGfX30pKGQvddas130_assertion description "[This indicates that persistent expression of the MET oncogene is mandatory until the advanced phases of cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615947.RAbs2vNyOV-0IXmBNNRUe3_WJoVKO1qGfX30pKGQvddas130_provenance.
- NP483448.RAlOAgXAnKGZTIg6xF7NaM2vRd28dAczwIhYA91jDM710130_assertion description "[This indicates that persistent expression of the MET oncogene is mandatory until the advanced phases of cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483448.RAlOAgXAnKGZTIg6xF7NaM2vRd28dAczwIhYA91jDM710130_provenance.
- NP471744.RAXKV9ZocVO4Xu5pp5YXtvaS4Mt3MoAdtNeHE6YbAQ3CU130_assertion description "[This indicates that persistent expression of the MET oncogene is mandatory until the advanced phases of cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471744.RAXKV9ZocVO4Xu5pp5YXtvaS4Mt3MoAdtNeHE6YbAQ3CU130_provenance.
- NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_assertion description "[This indicates that persistent expression of the MET oncogene is mandatory until the advanced phases of cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_provenance.
- assertion description "[This indicates that persistent expression of the MET oncogene is mandatory until the advanced phases of cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This indicates that persistent expression of the MET oncogene is mandatory until the advanced phases of cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP624032.RAUTU4M2myw6Fl6_DKXfkR18PVdSA_9TdwufQqcU5FhsU130_assertion description "[This indicates that persistent expression of the MET oncogene is mandatory until the advanced phases of cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624032.RAUTU4M2myw6Fl6_DKXfkR18PVdSA_9TdwufQqcU5FhsU130_provenance.
- NP624037.RAdU3B3nfbamUq9IrEFe0zOJyUoMTHzxTbT2c3Deig-rs130_assertion description "[This indicates that persistent expression of the MET oncogene is mandatory until the advanced phases of cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624037.RAdU3B3nfbamUq9IrEFe0zOJyUoMTHzxTbT2c3Deig-rs130_provenance.
- NP624035.RAFBr37-KmppAB8GiD38SDtWujVFoMUKnkQB6U-Gb-D7s130_assertion description "[This indicates that persistent expression of the MET oncogene is mandatory until the advanced phases of cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624035.RAFBr37-KmppAB8GiD38SDtWujVFoMUKnkQB6U-Gb-D7s130_provenance.